TriSalus Life Sciences, Inc.

TLSI

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001826667

SEC filings (opens in a new tab)

No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.

Other share classesTLSIW

Q1 2025 vs. Q4 2024

How the institutions holding TriSalus Life Sciences, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of TLSI: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Q1 2025	Change
Holders	28	34	+6
Shares	2.35M	2.95M	+602.1K (+25.7%)
Value	$11.8M	$16.3M	+$4.52M (+38.5%)

New holders (12)

Institutions that held TriSalus Life Sciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to TLSI in Q1 2025
Institution	Shares	Value	% of portfolio
Goldman Sachs Group Inc	33,900	$187.1K	0.00%
Citadel Advisors LLC	26,580	$146.7K	0.00%
HRT Financial LP	13,657	$75.0K	0.00%
Balyasny Asset Management LLC	10,804	$59.6K	0.00%
Two Sigma Securities, LLC	10,596	$58.5K	0.01%
Charles Schwab Investment Management Inc	10,000	$55.2K	0.00%
Prudential Financial Inc	10,000	$55.2K	0.00%
SRS Capital Advisors, Inc.	4,008	$22.1K	0.00%
Morgan Stanley	2,361	$13.0K	0.00%
Citigroup Inc	958	$5.29K	0.00%
Coldstream Capital Management Inc	150	$828	0.00%
Barclays PLC	32	$177	0.00%

Sold out (6)

Institutions that held TriSalus Life Sciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of TLSI in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Duquesne Family Office LLCSuperinvestorDuquesne Family Office	426,921	$2.14M
Angelo Gordon & Co., L.P.	10,854	$54.4K
Exos Asset Management LLC	3,604	$18.1K
Wolverine Asset Management LLC	1,032	$5.17K
Tower Research Capital LLC (TRC)	555	$2.78K
Advisor Group Holdings, Inc.	79	$395